Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis

Journal of Periodontal Research

Volumn 49, Issue 6, 2014, Pages 792-800

  Kim, J H ^a,b   Lee, D E ^a,b   Choi, S H ^b   Cha, J H ^a,b   Bak, E J ^b   Yoo, Y J ^a,b  

^a Yonsei University   (South Korea)

^b Yonsei University College of Dentistry   (South Korea)

Author keywords

Bone loss; Nicotinamide; Periodontitis; Streptozotocin

Indexed keywords

GLUCOSE BLOOD LEVEL; INSULIN; NICOTINAMIDE; OSTEOCLAST DIFFERENTIATION FACTOR; STREPTOZOCIN; VITAMIN B COMPLEX;

ALVEOLAR BONE LOSS; ANALYSIS; ANIMAL; BLOOD; BODY WEIGHT; BONE MATRIX; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FISCHER 344 RAT; FURCATION DEFECTS; GINGIVA; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; MALE; MICRO-COMPUTED TOMOGRAPHY; MOLAR TOOTH; MONONUCLEAR CELL; NEUTROPHIL; OSTEOLYSIS; PANCREAS ISLET BETA CELL; PATHOLOGY; PERIODONTITIS; PROCEDURES; RAT; TIBIA; WEIGHT REDUCTION;

ALVEOLAR BONE LOSS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BONE MATRIX; BONE RESORPTION; DIABETES MELLITUS, EXPERIMENTAL; FURCATION DEFECTS; GINGIVA; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; LEUKOCYTES, MONONUCLEAR; MALE; MOLAR; NEUTROPHILS; NIACINAMIDE; PERIODONTITIS; RANK LIGAND; RATS; RATS, INBRED F344; STREPTOZOCIN; TIBIA; VITAMIN B COMPLEX; WEIGHT LOSS; X-RAY MICROTOMOGRAPHY;

EID: 84909947719     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12165     Document Type: Article

References (30)

1. Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000 2007;44:127-153.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31(suppl 1):S55-S60.
3. Graves DT, Oates T, Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol 2011;3:5304.
4. Behl Y, Siqueira M, Ortiz J et al. Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen. J Immunol 2008;181:8711-8718.
5. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991;62:123-131.
6. Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Periodontol 2013;84:S113-S134.
7. Nassar H, Kantarci A, van Dyke TE. Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation. Periodontol 2000 2007;43:233-244.
8. Nishimura F, Iwamoto Y, Soga Y. The periodontal host response with diabetes. Periodontol 2000 2007;43:245-253.
9. Graves DT, Liu R, Oates TW. Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis. Periodontol 2000 2007;45:128-137.
10. Pontes Andersen CC, Flyvbjerg A, Buschard K, Holmstrup P. Relationship between periodontitis and diabetes: lessons from rodent studies. J Periodontol 2007;78:1264-1275.
11. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007;125:451-472.
12. Masiello P, Broca C, Gross R et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47:224-229.
13. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001;50:537-546.
14. Szkudelski T. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp Biol Med (Maywood) 2012;237:481-490.
15. Pierre W, Gildas AJ, Ulrich MC, Modeste WN, Benoit NT, Albert K. Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats. BMC Complement Altern Med 2012;12:264.
16. Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Shibasaki M. Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic rats. Basic Clin Pharmacol Toxicol 2008;103:560-568.
17. Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA 1992;268:3333-3337.
18. Hamann C, Kirschner S, Gunther KP, Hofbauer LC. Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 2012;8:297-305.
19. van Daele PL, Stolk RP, Burger H et al. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam study. Ann Intern Med 1995;122:409-414.
20. Sealand R, Razavi C, Adler RA. Diabetes mellitus and osteoporosis. Curr Diab Rep 2013;13:411-418.
21. Pacios S, Kang J, Galicia J et al. Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB J 2012;26:1423-1430.
22. Tobon-Arroyave SI, Isaza-Guzman DM, Restrepo-Cadavid EM, Zapata-Molina SM, Martinez-Pabon MC. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. J Clin Periodontol 2012;39:1132-1140.
23. Graves DT, Li J, Cochran DL. Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res 2011;90:143-153.
24. Kajiya M, Giro G, Taubman MA, Han X, Mayer MP, Kawai T. Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease. J Oral Microbiol 2010;2:5532.
25. Mori G, D'Amelio P, Faccio R, Brunetti G. The interplay between the bone and the immune system. Clin Dev Immunol 2013;2013:720504.
26. Roszer T. Inflammation as death or life signal in diabetic fracture healing. Inflamm Res 2011;60:3-10.
27. Zizzi A, Tirabassi G, Aspriello SD, Piemontese M, Rubini C, Lucarini G. Gingival advanced glycation end-products in diabetes mellitus-associated chronic periodontitis: an immunohistochemical study. J Periodontal Res 2013;48:293-301.
28. Franke S, Siggelkow H, Wolf G, Hein G. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Arch Physiol Biochem 2007;113:154-161.
29. Franke S, Ruster C, Pester J, Hofmann G, Oelzner P, Wolf G. Advanced glycation end products affect growth and function of osteoblasts. Clin Exp Rheumatol 2011;29:650-660.
30. Fulzele K, Riddle RC, DiGirolamo DJ et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010;142:309-319.